John George Rizk (John G Rizk)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Drug Administration

Coronavirus Disease

Helicobacter Pylori

Top Venues

BMJ open quality

BMJ evidence-based medicine

This page only lists publications with an associated author ORCID identifier.

Publications

John George Rizk, Jannat Saini, Kyungha Kim, Uzma Pathan, Danya M Qato
County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities. PloS one 19 (4) (2024)
John George Rizk, Jannat Saini, Kyungha Kim, Uzma Pathan, Danya M Qato
County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities. PloS one 19 (4) (2024)
John George Rizk, Jannat Saini, Kyungha Kim, Uzma Pathan, Danya M Qato
County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities. PloS one 19 (4) (2024)
John George Rizk, Julia F Slejko, Emily L Heil, Dominique Seo, Danya M Qato
Impact of the US Food and Drug Administration warning regarding increased risk of aortic aneurysms or aortic dissections on fluoroquinolone prescribing trends. BMJ open quality 13 (3) (2024)
John George Rizk, John C Lewin
FDA's dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps. BMJ evidence-based medicine (2022)
Kate C Chiang, John George Rizk, Deanna J Nelson, Lakshmanan Krishnamurti, Selvakumar Subbian, John D Imig, Imran Khan, Srinivasa T Reddy, Ajay Gupta
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath. Expert opinion on therapeutic targets 26 (1) (2022)
John George Rizk, Giuseppe Lippi, Brandon M Henry, Donald N Forthal, Youssef Rizk
Prevention and Treatment of Monkeypox. Drugs 82 (9) (2022)
John George Rizk, Carl J Lavie, Ajay Gupta
Low-dose aspirin for early COVID-19: does the early bird catch the worm? Expert opinion on investigational drugs 30 (8) (2021)
John George Rizk, Jose G Lazo, David Quan, Steven Gabardi, Youssef Rizk, Elani Streja, Csaba P Kovesdy, Kamyar Kalantar-Zadeh
Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients. Reviews in endocrine & metabolic disorders (2021)
Giovanni Carpenè, Diletta Onorato, Riccardo Nocini, Gianmarco Fortunato, John George Rizk, Brandon M Henry, Gian Luca Salvagno
Blood lactate concentration in COVID-19: a systematic literature review. Clinical chemistry and laboratory medicine (2021)
Rania M El-Lababidi, John George Rizk
Cefiderocol: A Siderophore Cephalosporin. The Annals of pharmacotherapy 54 (12) (2020)
John George Rizk, Kamyar Kalantar-Zadeh, Mandeep R Mehra, Carl J Lavie, Youssef Rizk, Donald N Forthal
Pharmaco-Immunomodulatory Therapy in COVID-19. Drugs 80 (13) (2020)
John George Rizk, Kamyar Kalantar-Zadeh, Mandeep R Mehra, Carl J Lavie, Youssef Rizk, Donald N Forthal
Authors' Reply to Vrachatis et al. "Pharmaco-Immunomodulatory Therapy I COVID-19". Drugs 80 (14) (2020)